BRKR vs DHR
BRKR: Bruker provides advanced analytical and diagnostic technology platforms that enable scientific breakthroughs in life sciences, materials research, and clinical applications. DHR: Danaher is a diversified conglomerate providing scientific instruments, diagnostics, and industrial solutions across life sciences, environmental monitoring, product identification, and healthcare globally.
Side-by-side fundamentals
| Metric | BRKR | DHR | Edge |
|---|---|---|---|
| Price as of 2026-08-10 close | $56.32 | $209.37 | |
| Market cap as of 2026-08-11 | $8.5B | $147.2B | |
| P/E as of 2026-08-11 | n/a | 36.20 | |
| PEG as of 2026-08-11 | 1.92 | 3.74 | BRKR lower |
| Net margin as of 2026-08-11 | -2.0% | +15.9% | DHR higher |
| Gross margin as of 2026-08-11 | +47.7% | +58.6% | DHR higher |
| Operating margin as of 2026-08-11 | -1.5% | +20.4% | DHR higher |
| ROE as of 2026-08-11 | -2.9% | +7.7% | DHR higher |
| ROA as of 2026-08-11 | -1.1% | +4.7% | DHR higher |
| Debt / equity as of 2026-08-11 | 0.77 | 0.51 | DHR lower |
| Revenue growth (YoY) as of 2026-08-11 | +1.6% | +4.6% | DHR higher |
| Revenue CAGR (3y) SEC XBRL | +10.7% | -2.7% | BRKR higher |
| Dividend yield as of 2026-08-11 | +0.4% | +0.8% | DHR higher |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-11 | 1.22 | 0.78 | |
| 1-year return as of 2026-08-10 close | +85.1% | +4.4% | BRKR higher |
Fundamentals: market data, as of 2026-08-11. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.